Andrew G. Muntean
Impact in
- Hematology top 1%
- Acute Myeloid Leukemia Research
- Molecular Biology top 5%
- Epigenetics and DNA Methylation
- Protein Degradation and Inhibitors
- Cancer-related gene regulation
- Histone Deacetylase Inhibitors Research
- Genomics and Chromatin Dynamics
- Connective Tissue Growth Factor Research
- RNA modifications and cancer
Papers in
- Hematology 27
- Acute Myeloid Leukemia Research 26
-
- Epigenetics and DNA Methylation 18
- Protein Degradation and Inhibitors 14
- Genomics and Chromatin Dynamics 10
- Ubiquitin and proteasome pathways 7
- Cancer-related gene regulation 6
- Histone Deacetylase Inhibitors Research 4
- Co-authors
- Jay L. Hess (18 shared papers)John D. Crispino (4 shared papers)Lester F. Lau (1 shared paper)Donna Beer Stolz (1 shared paper)Chih-Chiun Chen (1 shared paper)Fan‐E Mo (1 shared paper)Simon C. Watkins (1 shared paper)Jiaying Tan (4 shared papers)
- Journals
- Blood (11 papers)Cancer Cell (4 papers)Leukemia (3 papers)Oncotarget (3 papers)Nature Communications (2 papers)
- Partner nations
- United StatesCanadaPanama
In The Last Decade
Andrew G. Muntean
41 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 87
- Hematology 971
- Molecular Biology 2.1k
- Genetics 214
- Cancer Research 187
- Immunology 194
Countries citing papers authored by Andrew G. Muntean
This map shows the geographic impact of Andrew G. Muntean's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew G. Muntean with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew G. Muntean more than expected).
Fields of papers citing papers by Andrew G. Muntean
This network shows the impact of papers produced by Andrew G. Muntean. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew G. Muntean. The network helps show where Andrew G. Muntean may publish in the future.
Co-authors
The 25 scholars most cited alongside Andrew G. Muntean, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 386 | |
| 2 | 2002 | 361 | |
| 3 | 2015 | 321 | |
| 4 | 2011 | 281 | |
| 5 | 2010 | 194 | |
| 6 | 2011 | 137 | |
| 7 | 2005 | 103 | |
| 8 | 2018 | 103 | |
| 9 | 2007 | 90 | |
| 10 | 2007 | 83 | |
| 11 | 2009 | 70 | |
| 12 | 2014 | 68 | |
| 13 | 2015 | 53 | |
| 14 | 2008 | 49 | |
| 15 | 2011 | 49 | |
| 16 | 2015 | 44 | |
| 17 | 2020 | 38 | |
| 18 | 2012 | 36 | |
| 19 | 2021 | 36 | |
| 20 | 2014 | 35 |
About Andrew G. Muntean
Andrew G. Muntean is a scholar working on Hematology, Molecular Biology, Genetics, Cancer Research and Public Health, Environmental and Occupational Health, having authored 41 papers that have together received 2.8k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (26 papers), Epigenetics and DNA Methylation (18 papers), Protein Degradation and Inhibitors (14 papers), Genomics and Chromatin Dynamics (10 papers), Ubiquitin and proteasome pathways (7 papers), Cancer-related gene regulation (6 papers), Histone Deacetylase Inhibitors Research (4 papers) and Cancer Genomics and Diagnostics (3 papers). The work is most often cited by research in Hematology (971 citations), Molecular Biology (2.1k citations), Genetics (214 citations), Cancer Research (187 citations) and Immunology (194 citations). Andrew G. Muntean has collaborated with scholars based in United States, Canada and Panama. Frequent co-authors include Jay L. Hess, John D. Crispino, Lester F. Lau, Donna Beer Stolz, Chih-Chiun Chen, Fan‐E Mo, Simon C. Watkins, Jiaying Tan, Jingya Wang and Jolanta E. Grembecka. Their work appears in journals such as Blood, Cancer Cell, Leukemia, Oncotarget and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.